News Image

ArriVent Appoints John Hohneker, M.D., to its Board of Directors

Provided By GlobeNewswire

Last update: May 16, 2024

NEWTON SQUARE, Pa., May 16, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of John Hohneker, M.D. to its Board of Directors. Dr. Hohneker brings over 30 years of experience in biopharmaceutical leadership and drug development, and currently serves on the Boards of public companies Carisma Therapeutics, Inc. and Curis, Inc., and private companies Sonata Therapeutics and Trishula Therapeutics.

Read more at globenewswire.com

ARRIVENT BIOPHARMA INC

NASDAQ:AVBP (7/24/2025, 8:23:10 PM)

After market: 21.45 0 (0%)

21.45

-0.44 (-2.01%)



Find more stocks in the Stock Screener

Follow ChartMill for more